Breast Cancer
Reports from the United States and South Korea describe recent advances in breast cancer research
Published in Women's Health Weekly, September 14th, 2006
Study 1: HER2/neu-derived peptide GP2 is promising for use in a breast cancer vaccine.
According to a study from the United States, "E75 and GP2 are human leukocyte antigen (HLA)-A2-restricted immunogenic peptides derived from the HER2/neu protein. In a E75 peptide-based vaccine trial, pre-existing immunity and epitope spreading to GP2 was detected.
"The purpose of this study was to further investigate GP2 for potential use in vaccination strategies. Importantly, a naturally occurring polymorphism (I->V at position 2, 2VGP2) associated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Epithelial cells in nipple aspirate fluid may signify increased breast cancer risk - Breast Cancer
Gene regulation characteristic of tamoxifen may be an advantage over aromatase inhibitors - Cardiology
Atrial fibrillation recurrence after cardioversion is more prevalent in women than men - Obesity & Mortality
Premature death in women may be associated with moderate obesity at age 18 - Obstetrics
Breastfeeding in HIV-positive women may be associated with reduced mortality among offspring - Alcohol Use
Alcohol increases sleep intensity in young women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
